The creation of the null mutation for the c-Src proto-oncogene established that the expression of c-Src in osteoclasts is essential for osteoclast action and generation of ruffled borders and resorption lacunae. This molecule, and its upstream regulators and downstream substrate(s), represent the critical and central common pathway in osteoclastic bone resorption independent of how osteoclasts are stimulated. The major regulator of c-Src has recently been identified as c-Csk, a cytoplasmic tyrosine kinase which phosphorylates c-Src at Tyr 527 and renders c-Src inactive. However, c-Src is still phosphorylated at Tyr 527, even in Csk-deficient cells, suggesting the presence of other Csk-related kinases. These Csk-related kinases are distributed in a tissue- or cell-specific manner, implying that the Csk-related kinases may play a role in tissue-specific functions mediated by c-Src. The goals of the present application are to understand how Src protein expression and tyrosine kinase activity is regulated during osteoclastic bone resorption, and to identify Src-specific substrate(s).
The Specific Aims are: 1) to determine the precise molecular mechanisms by which c-Src is regulated in osteoclasts, by (a) cloning and expressing the Csk-related kinases, (b) examining the effects of Csk-related kinases on c-Src activity, (c) examining the expression of the Csk-related kinases in osteoclasts, in vitro and in vivo, and determining the relationship between expression and subcellular localization of c-Src with Csk, Csk-related kinases and c-Src substrates in cells resorbing bone, (d) determining the function of the Csk-related kinases in osteoclasts by examining the effects of antisense oligodeoxynucleotides, and over-expression of intact and mutated dominant-negative Csk-related kinases, and (e) determining the effects of osteotropic factors on subcellular localization and tyrosine phosphorylation of c-Src, Csk, Csk-related kinases and c-Src substrates, and correlating these changes with effects on bone resorption; and 2) to identify the target substrate(s) specific for c-Src in osteoclasts, and unravel the downstream signaling pathways utilized in osteoclasts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK045229-05
Application #
2016530
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Margolis, Ronald N
Project Start
1992-02-01
Project End
2001-01-31
Budget Start
1997-02-01
Budget End
1998-01-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Hiraga, Toru; Myoui, Akira; Hashimoto, Nobuyuki et al. (2012) Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. Cancer Res 72:4238-49
Yoneda, Toshiyuki; Hashimoto, Nobuyuki; Hiraga, Toru (2004) Bisphosphonate actions on bone and visceral metastases. Cancer Treat Res 118:213-29
Hiraga, Toru; Williams, Paul J; Ueda, Akimi et al. (2004) Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 10:4559-67
Mori, Yoshihisa; Shimizu, Nobuaki; Dallas, Mark et al. (2004) Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. Blood 104:2149-54
Myoui, Akira; Nishimura, Riko; Williams, Paul J et al. (2003) C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63:5028-33
Nishimura, Riko; Hata, Kenji; Ikeda, Fumiyo et al. (2003) The role of Smads in BMP signaling. Front Biosci 8:s275-84
Hata, Kenji; Nishimura, Riko; Ikeda, Fumiyo et al. (2003) Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14:545-55
Michigami, Toshimi; Hiraga, Toru; Williams, Paul J et al. (2002) The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs. Breast Cancer Res Treat 75:249-58
Nishimura, R; Hata, K; Harris, S E et al. (2002) Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31:303-12
Yi, Bing; Williams, Paul J; Niewolna, Marie et al. (2002) Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 62:917-23

Showing the most recent 10 out of 28 publications